Y-mAbs to Participate in Upcoming Investor Conferences in September
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical […]
Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference
AUSTIN, Texas, Sept. 03, 2024 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s […]
Avenue Therapeutics to Participate in Upcoming Investor Conferences
MIAMI, Sept. 03, 2024 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company […]
CVRx Announces Appointment of Two New Board Members
MINNEAPOLIS, Sept. 03, 2024 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, today announced the […]
Robinhood Markets, Inc. to Present at the Goldman Sachs Communacopia + Technology Conference on September 10, 2024
MENLO PARK, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) — Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today announced that it will […]
Femasys to Participate in Fireside Chat at the H.C. Wainwright 26th Annual Global Investment Conference
ATLANTA, Sept. 03, 2024 (GLOBE NEWSWIRE) — Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet […]
Clene to Present at the H.C. Wainwright 26th Annual Global Investment Conference
SALT LAKE CITY, Sept. 03, 2024 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its […]
BioVie Announces FDA Authorization of Investigational New Drug Application for Phase 2 Trial to Evaluate Bezisterim in Long COVID
Authorization expands use of bezisterim in a Phase 2, placebo-controlled, multicenter trial assessing bezisterim’s impact on neurological symptoms associated with […]
UPDATE — Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024
PRINCETON, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming […]
Maris-Tech Receives U.S. Patent for Innovative Forward Error Correction Optimization Method
The patented method reduces overhead data required in the forward error correction process based on specific characteristics of streamed media […]
